Pam Jayia

Pam Jayia has over a decade of experience in the medical and pharmaceutical sectors, notably serving as Medical Group Director and Global Medical Director in Clinical Safety at Roche from December 2019 to June 2025. Previously, Pam held positions at Biogen as Associate Director, Drug Safety Physician, and at Novo Nordisk as a Pharmaceutical Medicine Physician focused on Global Safety and Medical Affairs. Additional experience includes a pivotal role as Clinical Research Physician at MeDiNova Research and foundational training at West Midlands Deanery NHS Trust. Academic qualifications include an Executive MBA from Warwick Business School and a Doctor of Medicine from the University of Southampton.